PTPRC and neoplasm: To evaluate antigen-specific responses in the TME of mice treated with PRGN-2009, CD45+ tumor-infiltrating lymphocytes (TILs) were isolated and stimulated overnight in vitro with a mix of HPV16 E6/E7 15-mer peptides.